What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Fungus
- Microbiology
His scientific interests lie mostly in Microbiology, Caspofungin, Amphotericin B, Mucormycosis and Posaconazole.
His research on Microbiology frequently connects to adjacent areas such as Rhizopus microsporus.
The study incorporates disciplines such as Corpus albicans, Candida albicans and Echinocandin in addition to Caspofungin.
Within one scientific family, he focuses on topics pertaining to Internal medicine under Mucormycosis, and may sometimes address concerns connected to Lichtheimia corymbifera.
His Posaconazole research integrates issues from Acremonium, Amphotericin B deoxycholate and Intensive care medicine.
His Surgery research includes themes of Cancer, Liposomal amphotericin, Gastroenterology, Hematology and Skin infection.
His most cited work include:
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (543 citations)
- EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. (485 citations)
- ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others (269 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Microbiology, Amphotericin B, Aspergillus fumigatus, Voriconazole and Caspofungin.
All of his Microbiology and Itraconazole, Posaconazole, Candida albicans, Aspergillus and Etest investigations are sub-components of the entire Microbiology study.
In his study, which falls under the umbrella issue of Posaconazole, Identification is strongly linked to Mucormycosis.
His Flucytosine study in the realm of Amphotericin B interacts with subjects such as Antagonism.
His Voriconazole study combines topics in areas such as Internal medicine and In vitro.
His Caspofungin research is multidisciplinary, incorporating perspectives in Minimum inhibitory concentration, Echinocandin, Candida spp and Micafungin.
He most often published in these fields:
- Microbiology (80.97%)
- Amphotericin B (33.63%)
- Aspergillus fumigatus (25.66%)
What were the highlights of his more recent work (between 2018-2021)?
- Microbiology (80.97%)
- Amphotericin B (33.63%)
- Mucorales (16.81%)
In recent papers he was focusing on the following fields of study:
Eric Dannaoui mostly deals with Microbiology, Amphotericin B, Mucorales, Antifungal and Aspergillus fumigatus.
Aspergillus, Itraconazole, Posaconazole, Broth microdilution and Echinocandins are the subjects of his Microbiology studies.
His Amphotericin B study incorporates themes from Multiple drug resistance, Corpus albicans, Candida auris, Voriconazole and Pharmacology.
His work in the fields of Lichtheimia corymbifera overlaps with other areas such as Rhizopus arrhizus.
His Antifungal study combines topics from a wide range of disciplines, such as In vitro, Chromatography, Checkerboard, Etest and Agar.
His studies deal with areas such as Antibiosis, Antimicrobial, Rifampicin and Biofilm as well as Aspergillus fumigatus.
Between 2018 and 2021, his most popular works were:
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
- Invasive fungal diseases during COVID-19: We should be prepared. (50 citations)
- Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study “MFIP” (19 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Fungus
- Bacteria
Mucorales, Microbiology, In vivo, Caspofungin and Candida auris are his primary areas of study.
In general Mucorales study, his work on Lichtheimia corymbifera often relates to the realm of Rhizopus arrhizus, thereby connecting several areas of interest.
His works in Rhizomucor, Cryptococcus, Antifungal and Aspergillus are all subjects of inquiry into Microbiology.
In general Caspofungin, his work in Echinocandins is often linked to Context linking many areas of study.
His Candida auris research includes elements of Flucytosine, Multiple drug resistance and Voriconazole, Micafungin.
His Micafungin study is concerned with the larger field of Amphotericin B.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
